Workflow
Janux Therapeutics (JANX) Surges 6.8%: Is This an Indication of Further Gains?

Janux Therapeutics, Inc. (JANX) shares soared 6.8% in the last trading session to close at $25.85. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 0.5% loss over the past four weeks.The sudden stock price rise can be attributed to positive investor expectations for the company’s pipeline. The most advanced candidates in Janux’s pipeline are JANX007 and JANX008 which are being evaluated in early-stage clinical studies for prostate ...